4//SEC Filing
Audia James E 4
Accession 0001562180-19-005410
CIK 0001434418other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 5:00 PM ET
Size
9.2 KB
Accession
0001562180-19-005410
Insider Transaction Report
Form 4
Audia James E
Director
Transactions
- Sale
Common Stock
2019-11-06$18.58/sh−10,500$195,076→ 46,534 total - Sale
Common Stock
2019-11-06$17.55/sh−4,500$78,978→ 57,034 total - Sale
Common Stock
2019-11-06$19.11/sh−7,500$143,357→ 39,034 total
Footnotes (4)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $17.39to $17.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $18.00 to $18.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $19.00 to $19.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
CONSTELLATION PHARMACEUTICALS INC
CIK 0001434418
Entity typeother
Related Parties
1- filerCIK 0001746115
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 5:00 PM ET
- Size
- 9.2 KB